• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Yi Chuan. The 2019 novel coronavirus resource

tetano

Editor, Senior Moderator
Yi Chuan. 2020 Feb 20;42(2):212-221. doi: 10.16288/j.yczz.20-030. [h=1]The 2019 novel coronavirus resource.[/h]
Zhao WM[SUP]1[/SUP], Song SH[SUP]2[/SUP], Chen ML[SUP]2[/SUP], Zou D[SUP]2[/SUP], Ma LN[SUP]2[/SUP], Ma YK[SUP]2[/SUP], Li RJ[SUP]2[/SUP], Hao LL[SUP]2[/SUP], Li CP[SUP]2[/SUP], Tian DM[SUP]2[/SUP], Tang BX[SUP]2[/SUP], Wang YQ[SUP]2[/SUP], Zhu JW[SUP]2[/SUP], Chen HX[SUP]2[/SUP], Zhang Z[SUP]1[/SUP], Xue YB[SUP]3[/SUP], Bao YM[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] in English, Chinese
An ongoing outbreak of a novel coronavirus infection in Wuhan, China since December 2019 has led to 31,516 infected persons and 638 deaths across 25 countries (till 16:00 on February 7, 2020). The virus causing this pneumonia was then named as the 2019 novel coronavirus (2019-nCoV) by the World Health Organization. To promote the data sharing and make all relevant information of 2019-nCoV publicly available, we construct the 2019 Novel Coronavirus Resource (2019nCoVR, https://bigd.big.ac.cn/ncov). 2019nCoVR features comprehensive integration of genomic and proteomic sequences as well as their metadata information from the Global Initiative on Sharing All Influenza Data, National Center for Biotechnology Information, China National GeneBank, National Microbiology Data Center and China National Center for Bioinformation (CNCB)/National Genomics Data Center (NGDC). It also incorporates a wide range of relevant information including scientific literatures, news, and popular articles for science dissemination, and provides visualization functionalities for genome variation analysis results based on all collected 2019-nCoV strains. Moreover, by linking seamlessly with related databases in CNCB/NGDC, 2019nCoVR offers virus data submission and sharing services for raw sequence reads and assembled sequences. In this report, we provide comprehensive descriptions on data deposition, management, release and utility in 2019nCoVR, laying important foundations in aid of studies on virus classification and origin, genome variation and evolution, fast detection, drug development and pneumonia precision prevention and therapy.


[h=4]KEYWORDS:[/h] 2019 novel coronavirus; 2019nCoVR; China National Center for Bioinformation (CNCB); National Genomics Data Center (NGDC); genomic data sharing

PMID: 32102777 DOI: 10.16288/j.yczz.20-030
 
Back
Top